This is first study to show that metformin targets pSTAT3 by degrading the protein and suppresses the upstream regulator JAK2 as well as the positive feedback regulator pNF-κB proteins in type 1 endometrial cancer cells. The gene discussed is JAK2; the disease is endometrial cancer.